Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “chimeric”

309 pharma patents match "chimeric" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 309
Index total 30,257
Page 12 / 13

Quick answer

This filtered view shows 309 pharmaceutical patents matching "chimeric" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

309 results for “chimeric” · 30,257 patents in full index Clear search

  1. US 7691386

    Chimeric papillomavirus-like particles

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Apr 6, 2010 · Expires Apr 1, 2030

    granted

  2. US 7662394

    Nucleic acids encoding chimeric Flavivirus immunogens comprising the Japanese encephalitis virus (JEV) PRM signal sequence

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  3. US 7632508

    Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

    The United States of America · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted

  4. US 7622123

    Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

  5. US 7578998

    Chimeric cytokine of IL-7 and beta-chain of HGF and methods of use

    UNIVERSITY OF CONNECTICUT · Granted Aug 25, 2009 · Expires Aug 20, 2029

    granted

  6. US 7569542

    Anti-microbial targeting chimeric pharmaceutical

    The Regents of the University of California · Granted Aug 4, 2009 · Expires Jul 30, 2029

    granted

  7. US 7541040

    Chimeric molecule for the treatment of th2-like cytokine mediated disorders

    The United States of America as represented by the Department of Health and Human Serivces · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  8. US 7524944

    Chimeric nucleic acids encoding polypeptides comprising CD154 and TNF-α

    The Regents of the University of California · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  9. US 7524499

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 28, 2009 · Expires Apr 23, 2029

    granted

  10. US 7521211

    IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 21, 2009 · Expires Apr 16, 2029

    granted

  11. US 7517531

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  12. US 7495090

    Nucleic acids encoding chimeric CD154 polypeptides

    The Regents of the University of California · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted

  13. US 7473772

    Chimeric GB virus B (GBV-B)

    The Board of Regents of the University of Texas System · Granted Jan 6, 2009 · Expires Jan 1, 2029

    granted

  14. US 7462356

    Chimeric papillomavirus-like particles

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted

  15. US 7404956

    Immunoglobulin chimeric monomer-dimer hybrids

    Syntonix Pharmaceuticals, Inc. · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  16. US 7393833

    Chimeric proteins with phosphatidylserine binding domains

    The Board of Regents of the University of Oklahoma · Granted Jul 1, 2008 · Expires Jun 26, 2028

    granted

  17. US 7381408

    Methods for chemically synthesizing immunoglobulin chimeric proteins

    Syntonix Pharmaceuticals, Inc. · Granted Jun 3, 2008 · Expires May 29, 2028

    granted

  18. US 7374757

    Modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted May 20, 2008 · Expires May 15, 2028

    granted

  19. US 7374758

    Modified chimeric polypeptides with improved pharmacokinetic properties and methods of using thereof

    REGENERON PHARMACEUTICALS, INC. · Granted May 20, 2008 · Expires May 15, 2028

    granted

  20. US 7348004

    Immunoglobulin chimeric monomer-dimer hybrids

    Syntonix Pharmaceuticals, Inc. · Granted Mar 25, 2008 · Expires Mar 20, 2028

    granted

  21. US 7314625

    Chimeric protein comprising non-toxic Pseudomonas exotoxin A and Type IV pilin sequences

    The United States as represented by the Secretary of the Department of Health and Human Services · Granted Jan 1, 2008 · Expires Dec 27, 2027

    granted

  22. US 7314632

    Pseudomonas exotoxin A-like chimeric immunogens

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 1, 2008 · Expires Dec 27, 2027

    granted

  23. US 7303746

    Methods of treating eye disorders with modified chimeric polypeptides

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted

  24. US 7267978

    Chimeric transcriptional regulatory element compositions and methods for increasing prostate-targeted gene expression

    The Regents of the University of California · Granted Sep 11, 2007 · Expires Sep 6, 2027

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.